Get 20% lifetime commission for referring investors to digrin.com
here.
Lexicon Pharmaceuticals, Inc. ( LXRX) - Key Metrics
LXRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.07 | -$0.05 | -$0.05 |
| 2026Q1 | $0.05 | $0 | -$0.04 | -$0.04 |
| 2025Q4 | $0.02 | -$0.04 | -$0.05 | -$0.05 |
| 2025Q3 | $0.04 | -$0.04 | -$0.07 | -$0.07 |
| 2025Q2 | $0.08 | $0.01 | $0.05 | $0.05 |
LXRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.57 |
| 2026Q1 | 0% | -150 |
| 2025Q4 | 0% | -6.73 |
| 2025Q3 | 0% | -9.62 |
| 2025Q2 | 0% | 26.27 |
LXRX
Price: $2.34
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.15 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 131023
Ebitda: -28.2 millionMarket Capitalization: 1.0 billion